A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemia.
about
Treatment of CD33-directed chimeric antigen receptor-modified T cells in one patient with relapsed and refractory acute myeloid leukemia.A phase I study of midostaurin and azacitidine in relapsed and elderly AML patientsAssociation between early promoter-specific DNA methylation changes and outcome in older acute myeloid leukemia patients.A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome.Gemtuzumab ozogamicin in acute myeloid leukemia revisited.Novel drugs for older patients with acute myeloid leukemia.Management of Newly Diagnosed Acute Myeloid Leukemia in the Elderly: Current Strategies and Future Directions.Recent developments in immunotherapy of acute myeloid leukemia.Antibody-Drug Conjugates: A Clinical Pharmacy Perspective on an Emerging Cancer Therapy.The safety of treatment options for elderly people with acute myeloid leukemia.Acute Myeloid Leukemia in the Elderly Patient: New StrategiesHypomethylating Agents as a Therapy for AML.Cyanobacteria from terrestrial and marine sources contain apoptogens able to overcome chemoresistance in acute myeloid leukemia cells.Treatment of Elderly Patients With Acute Myeloid Leukemia.Relationship between event-free survival and overall survival in acute myeloid leukemia: a report from SWOG, HOVON/SAKK, and MRC/NCRI.New drug approvals in acute myeloid leukemia: what's the best end point?The rocky road to personalized medicine in acute myeloid leukaemia.Precision therapy for acute myeloid leukemia.The management and treatment of acute leukemias in the elderly population.Initial therapy for acute myeloid leukemia in older patients: principles of care.Post-transplant maintenance therapy with azacitidine and gemtuzumab ozogamicin for high-risk acute myeloid leukaemia.Comparable Outcomes of Patients Eligible versus Ineligible for SWOG Leukemia Studies.
P2860
Q35591409-0B2B3EA7-7D55-479F-A668-644C5ACB3FB7Q35793176-FFB997A0-7698-4968-AC72-1AA402BD8FD2Q36655704-B0CF7BC5-B534-4881-920A-0BF14209896BQ36682845-F4D3CF94-DE48-417B-8F08-143ACA77EA35Q38215269-968603BE-7457-4435-97EA-7442495FF277Q38241761-AB3CF1E4-301D-428B-97B5-94D54F62F178Q38601723-CCA4C616-EADD-4B1B-8D44-39F7EEAE873FQ38661895-D7928416-F9B9-4F93-A4B9-99DBC57CE481Q38707852-F67058D9-06C5-46D4-A7F7-8C9C945CA073Q38760822-9C16F157-C4AF-44EF-A91D-64CE3222B9BAQ38835119-00B82270-50A2-4C23-B56F-056188B5174DQ38911864-0C91761F-55D7-4662-8ADB-8A0F9C8ECE6CQ39007306-C8ED6CC0-63A9-4CF1-BEFB-AD25F722904CQ39112940-B72FABBE-EA43-4A5E-BF5E-7F63483E0C44Q42399829-25448CA6-6216-4F9F-8C55-61558A4CAA89Q42637732-3C636129-CF8F-4822-ADF3-1246A4E1F743Q47561008-727120B7-DBFB-42EF-A42F-8743842391BEQ49534332-4219F910-16BA-4AF4-A0E0-F5E11B87C6CEQ49987424-3DFF6D9D-0332-4D10-93E4-68867A9826E3Q52767299-EAA77D40-4568-4E6D-B48A-067425FC64C1Q52981533-9EFE7BB2-0130-4E1D-A9FF-1FFBA7B28AB8Q53832560-6F045F85-88F9-4DB0-ABB6-A43C694D0A6F
P2860
A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A phase 2 trial of azacitidine ...... s with acute myeloid leukemia.
@en
A phase 2 trial of azacitidine ...... s with acute myeloid leukemia.
@nl
type
label
A phase 2 trial of azacitidine ...... s with acute myeloid leukemia.
@en
A phase 2 trial of azacitidine ...... s with acute myeloid leukemia.
@nl
prefLabel
A phase 2 trial of azacitidine ...... s with acute myeloid leukemia.
@en
A phase 2 trial of azacitidine ...... s with acute myeloid leukemia.
@nl
P2093
P2860
P1433
P1476
A phase 2 trial of azacitidine ...... s with acute myeloid leukemia.
@en
P2093
Cheryl L Willman
Dianna S Howard
Harry P Erba
John E Godwin
Steven E Coutre
Sucha Nand
Thomas H Norwood
P2860
P304
P356
10.1182/BLOOD-2013-06-506592
P407
P577
2013-10-03T00:00:00Z